Iqvia Holdings, Inc. · NYSE:IQV
Iqvia — IQVIA Life Sciences Innovation Forum (September 2022)
9 slides from Iqvia's conference presentation, Sep 13, 2022
Slide 1: IQVIA Life Sciences Innovation Forum: Evolving the Biomedical Innovation System
IQVIA Life Sciences Innovation Forum S e t - u p S l i d e s : E vo l vi n g t h e B i o m e d i c a l I n n o va t i o n S ys t e m September 13, 2022 Copyright © 2021 IQVIA. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States and various other countries.
Slide 2: Today's biomedical R&D pipeline innovation levels at all time highs
Today’s biomedical R&D pipeline innovation levels at all time highs CAGR for illustrated period US Lifesciences Venture Pharmaceutical Pipeline Funding 7,000 +105% 2020-21 +17% 2020-21 50 6,000 Deal Value ($B) 6% 40 5,000 20% 30 4,000 20 3,000 2,000 10 1,000 0 0 2012 2016 2021 2011 2016 2021 Total T
Slide 3: Clinical complexity growing faster than underlying pipeline
Examples clinical complexity growing faster than underlying pipeline Emerging Biopharma Pipeline Next Generation Pipeline 7000 7000 6000 6000 6% 6% Number of Pipeline Products 5000 5000 4000 4000 1% 5% 3000 3000 2000 2000 10% 1000 1000 16% 0 0 2011 2016 2021 2011 2016 2021 Pharmaceutical Pipeline As
Slide 4: New launches suggesting greater rate of innovation coming through the pipeline
New launches also suggesting greater rate of innovation coming through the pipeline First in class Biologic Specialty Orphan 100% 100% 100% 90% 100% 90% 90% 80% 80% 80% 70% 80% 70% 70% 60% 60% 60% 60% 50% 50% 50% 40% 40% 40% 40% 30% 30% 30% 20% 20% 20% 20% 10% 10% 10% 0% 0% 0% 0% 2017 2018 2019 2020
Slide 5: Industry facing productivity challenge in translating pipeline innovation to new medicines
Despite investment, industry facing productivity challenge in translating pipeline innovation to new medicines IQVIA Institute Clinical Development Productivity Index The productivity of the clinical development process can be estimated from a measure of trial outputs (drugs, innovation, trial succe
Slide 6: Ongoing complexities and societal demands will continue to evolve the innovation system
Ongoing complexities and societal demands will continue to evolve the innovation system and effect productivity Increasing proportion of scientific Clinical Development Productivity Index and elements of productivity indexed to innovation in the pipeline contributing to 2010 values reduced probabili
Slide 7: Ongoing complexities and societal demands will continue to evolve the innovation system
Ongoing complexities and societal demands will continue to evolve the innovation system and effect productivity Increasing proportion of scientific Clinical Development Productivity Index and elements of productivity indexed to innovation in the pipeline contributing to 2010 values reduced probabili
Slide 8: Opportunity to harness clinical innovations to address productivity challenges
Discussion Starter Opportunity to harness clinical innovations to address productivity challenges Productivity Enablers Collaborative Evolving trial Digital Health Decentralization models (public- Predictive models (novel Biomarkers (Sensors, / Patient- RWE private, Analytics/ AI/ML trial design, in
Slide 9: Evolving the Biomedical Innovation System: Areas for discussion
Evolving the Biomedical Innovation System Areas for discussion Role of real world evidence and advanced analytics Where and when can real-world data and advanced analytics including AI/ML be best applied to advance biomedical research? Clinical trial productivity What areas of significant “white spa
Iqvia — IQVIA Life Sciences Innovation Forum (September 2022) on 6ix